Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
09 2020
Historique:
received: 17 06 2020
revised: 19 06 2020
accepted: 23 06 2020
pubmed: 13 7 2020
medline: 2 9 2020
entrez: 13 7 2020
Statut: ppublish

Résumé

In April, 2020, clinicians in the UK observed a cluster of children with unexplained inflammation requiring admission to paediatric intensive care units (PICUs). We aimed to describe the clinical characteristics, course, management, and outcomes of patients admitted to PICUs with this condition, which is now known as paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). We did a multicentre observational study of children (aged <18 years), admitted to PICUs in the UK between April 1 and May 10, 2020, fulfilling the case definition of PIMS-TS published by the Royal College of Paediatrics and Child Health. We analysed routinely collected, de-identified data, including demographic details, presenting clinical features, underlying comorbidities, laboratory markers, echocardiographic findings, interventions, treatments, and outcomes; serology information was collected if available. PICU admission rates of PIMS-TS were compared with historical trends of PICU admissions for four similar inflammatory conditions (Kawasaki disease, toxic shock syndrome, haemophagocytic lymphohistiocytosis, and macrophage activation syndrome). 78 cases of PIMS-TS were reported by 21 of 23 PICUs in the UK. Historical data for similar inflammatory conditions showed a mean of one (95% CI 0·85-1·22) admission per week, compared to an average of 14 admissions per week for PIMS-TS and a peak of 32 admissions per week during the study period. The median age of patients was 11 years (IQR 8-14). Male patients (52 [67%] of 78) and those from ethnic minority backgrounds (61 [78%] of 78) were over-represented. Fever (78 [100%] patients), shock (68 [87%]), abdominal pain (48 [62%]), vomiting (49 [63%]), and diarrhoea (50 [64%]) were common presenting features. Longitudinal data over the first 4 days of admission showed a serial reduction in C-reactive protein (from a median of 264 mg/L on day 1 to 96 mg/L on day 4), D-dimer (4030 μg/L to 1659 μg/L), and ferritin (1042 μg/L to 757 μg/L), whereas the lymphocyte count increased to more than 1·0 × 10 During the study period, the rate of PICU admissions for PIMS-TS was at least 11-fold higher than historical trends for similar inflammatory conditions. Clinical presentations and treatments varied. Coronary artery aneurysms appear to be an important complication. Although immediate survival is high, the long-term outcomes of children with PIMS-TS are unknown. None.

Sections du résumé

BACKGROUND
In April, 2020, clinicians in the UK observed a cluster of children with unexplained inflammation requiring admission to paediatric intensive care units (PICUs). We aimed to describe the clinical characteristics, course, management, and outcomes of patients admitted to PICUs with this condition, which is now known as paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS).
METHODS
We did a multicentre observational study of children (aged <18 years), admitted to PICUs in the UK between April 1 and May 10, 2020, fulfilling the case definition of PIMS-TS published by the Royal College of Paediatrics and Child Health. We analysed routinely collected, de-identified data, including demographic details, presenting clinical features, underlying comorbidities, laboratory markers, echocardiographic findings, interventions, treatments, and outcomes; serology information was collected if available. PICU admission rates of PIMS-TS were compared with historical trends of PICU admissions for four similar inflammatory conditions (Kawasaki disease, toxic shock syndrome, haemophagocytic lymphohistiocytosis, and macrophage activation syndrome).
FINDINGS
78 cases of PIMS-TS were reported by 21 of 23 PICUs in the UK. Historical data for similar inflammatory conditions showed a mean of one (95% CI 0·85-1·22) admission per week, compared to an average of 14 admissions per week for PIMS-TS and a peak of 32 admissions per week during the study period. The median age of patients was 11 years (IQR 8-14). Male patients (52 [67%] of 78) and those from ethnic minority backgrounds (61 [78%] of 78) were over-represented. Fever (78 [100%] patients), shock (68 [87%]), abdominal pain (48 [62%]), vomiting (49 [63%]), and diarrhoea (50 [64%]) were common presenting features. Longitudinal data over the first 4 days of admission showed a serial reduction in C-reactive protein (from a median of 264 mg/L on day 1 to 96 mg/L on day 4), D-dimer (4030 μg/L to 1659 μg/L), and ferritin (1042 μg/L to 757 μg/L), whereas the lymphocyte count increased to more than 1·0 × 10
INTERPRETATION
During the study period, the rate of PICU admissions for PIMS-TS was at least 11-fold higher than historical trends for similar inflammatory conditions. Clinical presentations and treatments varied. Coronary artery aneurysms appear to be an important complication. Although immediate survival is high, the long-term outcomes of children with PIMS-TS are unknown.
FUNDING
None.

Identifiants

pubmed: 32653054
pii: S2352-4642(20)30215-7
doi: 10.1016/S2352-4642(20)30215-7
pmc: PMC7347350
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

669-677

Subventions

Organisme : Department of Health
ID : CS-2015-15-016
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
J Formos Med Assoc. 2014 Mar;113(3):148-54
pubmed: 24495555
Lancet Child Adolesc Health. 2020 Aug;4(8):e28-e29
pubmed: 32553126
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Br J Gen Pract. 2016 Apr;66(645):e271-6
pubmed: 26906631
Lancet. 2020 May 9;395(10235):1517-1520
pubmed: 32311318
JAMA Pediatr. 2020 Apr 8;:
pubmed: 32267485
PLoS One. 2013 Sep 18;8(9):e74529
pubmed: 24058585
Pediatrics. 2009 May;123(5):e783-9
pubmed: 19403470
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Pediatr Cardiol. 2020 Oct;41(7):1391-1401
pubmed: 32529358
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Arch Dis Child. 2009 Mar;94(3):210-5
pubmed: 19106117
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235

Auteurs

Patrick Davies (P)

Paediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK. Electronic address: patrick.davies@nuh.nhs.uk.

Claire Evans (C)

Paediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK.

Hari Krishnan Kanthimathinathan (HK)

Paediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Jon Lillie (J)

Paediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.

Joseph Brierley (J)

Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.

Gareth Waters (G)

Paediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.

Mae Johnson (M)

Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.

Benedict Griffiths (B)

Paediatric Intensive Care Unit, Evelina Children's Hospital, London, UK.

Pascale du Pré (P)

Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, UK.

Zoha Mohammad (Z)

Paediatric Intensive Care Unit, Leicester Royal Infirmary, Leicester, UK.

Akash Deep (A)

Paediatric Intensive Care Unit, King's College Hospital, London, UK.

Stephen Playfor (S)

Paediatric Intensive Care Unit, Royal Manchester Children's Hospital, Manchester, UK.

Davinder Singh (D)

Paediatric Intensive Care Unit, Leeds Royal Infirmary, Leeds, UK.

David Inwald (D)

Paediatric Intensive Care Unit, Addenbrooke's Hospital, Cambridge, UK.

Michelle Jardine (M)

Paediatric Critical Care Unit, Children's Hospital for Wales, Cardiff, UK.

Oliver Ross (O)

Paediatric Intensive Care Unit, Southampton Children's Hospital, Southampton, UK.

Nayan Shetty (N)

Paediatric Intensive Care Unit, Alder Hey Children's Hospital, Liverpool, UK.

Mark Worrall (M)

Paediatric Intensive Care Unit, Royal Hospital for Children, Glasgow, UK.

Ruchi Sinha (R)

Paediatric Intensive Care Unit, St Mary's Hospital, London, UK.

Ashwani Koul (A)

Paediatric Critical Care Unit, John Radcliffe Hospital, Oxford, UK.

Elizabeth Whittaker (E)

Paediatric Infectious Diseases Department, Imperial College Healthcare NHS Trust, London, UK.

Harish Vyas (H)

Paediatric Critical Care Unit, Nottingham Children's Hospital, Nottingham, UK.

Barnaby R Scholefield (BR)

Paediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

Padmanabhan Ramnarayan (P)

Paediatric Intensive Care Unit, St Mary's Hospital, London, UK; Children's Acute Transport Service, Great Ormond Street Hospital NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH